Gordon Lavigne, MEd

home / authors / gordon-lavigne-med

Mr Lavigne is the chief executive officer of the Schizophrenia & Psychosis Action Alliance.

Articles

Advocacy Group Applaud Joint FDA Committee Proposed Changes to Clozapine REMS Requirements

Advocacy Group Applaud Joint FDA Committee Proposed Changes to Clozapine REMS Requirements

Heidi Anne Duerr, MPH;Gordon Lavigne, MEd

November 26th 2024

Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: December 29th 2024

Mini Quiz: Treatment for Pedophilia?

winter

Published: December 20th 2024 | Updated: December 29th 2024

Poll: How Are You Handling the Holidays as a Clinician?

Mini Quiz: Effects of Lead Exposure on Children

Published: November 15th 2016 | Updated: December 29th 2024

Mini Quiz: Effects of Lead Exposure on Children

Poor DSM-5—So Misunderstood!

Published: March 23rd 2021 | Updated: December 29th 2024

Poor DSM-5—So Misunderstood!

Mini Quiz: Methods of Suicide

Published: January 21st 2016 | Updated: December 29th 2024

Mini Quiz: Methods of Suicide

Mini Quiz: Cognitive Enhancers

Published: October 1st 2020 | Updated: December 29th 2024

Mini Quiz: Cognitive Enhancers

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.